Celldex Therapeutics, Inc. (CLDX) total assets

Total assets · fiscal 2025
$582.98M

Celldex Therapeutics, Inc. (CLDX) had total assets of $582.98M at the end of fiscal 2025 (December 31, 2025). That is 26.4% lower than the $792.34M of fiscal 2024. Figures as of 18 Nov 2026, 01:32 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$582.98M
Change on fiscal 2024
−26.4%
Growth, 5 years
+19.8% a year
Growth, 10 years
+5.6% a year
Highest on record
$792.34Mfiscal 2024
Lowest on record
$97.99Mfiscal 2011
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Celldex Therapeutics, Inc. total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 19.8% a year; over ten years the rate was 5.6% a year. Across the 16 fiscal years on record (2010–2025), the highest was $792.34M in fiscal 2024 and the lowest $97.99M in fiscal 2011.

History · 16 fiscal years

Total assets by fiscal year

Celldex Therapeutics, Inc. total assets, year by year

Celldex Therapeutics, Inc. (CLDX) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$582.98M 26.4% down
2024$792.34M 70.2% up
2023$465.63M 32.0% up
2022$352.74M 20.7% down
2021$444.65M 88.5% up
2020$235.84M 91.8% up
2019$122.93M 21.1% down
2018$155.81M 50.6% down
2017$315.62M 17.7% down
2016$383.36M 13.6% up
2015$337.58M 36.1% up
2014$248.01M 28.5% down
2013$347.10M 176.5% up
2012$125.54M 28.1% up
2011$97.99M 10.9% down
2010$109.94M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

More on CLDX

Celldex Therapeutics, Inc., figure by figure

Celldex Therapeutics, Inc. (CLDX) overview: price, valuation and scorecard

Celldex Therapeutics, Inc. total assets: questions and answers

How large are Celldex Therapeutics, Inc.'s total assets?

Celldex Therapeutics, Inc. (CLDX) had total assets of $582.98M at the end of fiscal 2025 (December 31, 2025). That is 26.4% lower than the $792.34M of fiscal 2024.

What is the growth rate of Celldex Therapeutics, Inc.'s total assets?

Over the five fiscal years to 2025 total assets grew at a compound 19.8% a year; over ten years the rate was 5.6% a year.

What are the highest and lowest total assets figures on record for Celldex Therapeutics, Inc.?

Across the 16 fiscal years on record (2010–2025), the highest was $792.34M in fiscal 2024 and the lowest $97.99M in fiscal 2011.

How is Celldex Therapeutics, Inc.'s total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Celldex Therapeutics, Inc. (CLDX) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/CLDX/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.